Mesenchymal stem cell therapy for doxorubicin cardiomyopathy: hopes and fears (2015)
Source: Stem Cell Research & Therapy. Unidade: FMRP
Subjects: MIOCARDIOPATIA CONGESTIVA, ANTINEOPLÁSICOS, CÉLULAS-TRONCO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
EZQUER, Fernando et al. Mesenchymal stem cell therapy for doxorubicin cardiomyopathy: hopes and fears. Stem Cell Research & Therapy, v. 6, 2015Tradução . . Disponível em: https://doi.org/10.1186/s13287-015-0109-y. Acesso em: 03 out. 2024.APA
Ezquer, F., Gutiérrez, J., Ezquer, M., Caglevic, C., Salgado, H. C., & Calligaris, S. D. (2015). Mesenchymal stem cell therapy for doxorubicin cardiomyopathy: hopes and fears. Stem Cell Research & Therapy, 6. doi:10.1186/s13287-015-0109-yNLM
Ezquer F, Gutiérrez J, Ezquer M, Caglevic C, Salgado HC, Calligaris SD. Mesenchymal stem cell therapy for doxorubicin cardiomyopathy: hopes and fears [Internet]. Stem Cell Research & Therapy. 2015 ; 6[citado 2024 out. 03 ] Available from: https://doi.org/10.1186/s13287-015-0109-yVancouver
Ezquer F, Gutiérrez J, Ezquer M, Caglevic C, Salgado HC, Calligaris SD. Mesenchymal stem cell therapy for doxorubicin cardiomyopathy: hopes and fears [Internet]. Stem Cell Research & Therapy. 2015 ; 6[citado 2024 out. 03 ] Available from: https://doi.org/10.1186/s13287-015-0109-y